Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Taking a second dose of Ambien (zolpidem) in the same night is generally not recommended and can be dangerous, because it raises your risk of next-day drowsiness, memory gaps, complex sleep behaviors like sleepwalking or sleep-driving, breathing suppression, and falls. Risk rises sharply if Ambien is combined with alcohol, opioids, benzodiazepines, or other sedatives, and in older adults, people with liver or lung disease, and anyone who has fewer than 7 to 8 hours left to sleep. Persistent trouble falling asleep even after a dose may signal an underlying issue such as anxiety, pain, sleep apnea, restless legs, or medication tolerance rather than a need for more medication. There are several important safety factors and warning signs to consider before ever repeating a dose, so see below to understand more.
If you are lying awake, unsure whether your symptoms are a medication effect, a sleep disorder, or something more serious, a free, instant, online symptom check can help you clarify what is likely going on and decide whether to call your prescriber, seek urgent care, or address it at your next visit.
Last reviewed for medical accuracy: 09/12/2026
Is It Dangerous to Take a Second Ambien If You’re Still Awake?
When sleep just won’t come, it’s tempting to take another dose of Ambien (generic name: zolpidem) and hope for the best. Ambien is a prescription sleep aid designed to help you fall asleep faster, but it carries specific dosing guidelines for a reason. Taking more than your prescribed amount—or dosing twice in one night—can increase the risk of serious side effects. Here’s what you need to know.
Ambien belongs to a class of drugs called non-benzodiazepine hypnotics. It acts on the brain’s GABA receptors to slow down activity, helping you drift off to sleep.
• Typical doses:
Key point: Ambien is intended for once-a-night use, immediately before bedtime, when you can devote a full night to sleep.
According to the U.S. Food and Drug Administration (FDA) label and clinical practice guidelines:
Taking a second dose of Ambien in one night—even if you’re still awake—can lead to:
If you experience any of the following after taking Ambien, seek medical attention immediately:
For non-emergencies—such as persistent insomnia, daytime drowsiness or questions about your Ambien dose—you might try a free, online symptom check, using the doctor approved Ubie Symptom Checker.
If you ever have concerns about side effects, unusual behaviors or life-threatening symptoms, please speak to a doctor or call emergency services right away. Your safety is the top priority.
(References)
* Valero E, Bousquet A, Almon M, Vest P, Ceppa F, Pelletier C, Renard C. [Multidrug intoxication]. Ann Biol Clin (Paris). 2009 Mar-Apr;67(2):227-32. doi: 10.1684/abc.2009.0316. PMID: 19297297.
* Schroeck JL, Ford J, Conway EL, Kurtzhalts KE, Gee ME, Vollmer KA, Mergenhagen KA. Review of Safety and Efficacy of Sleep Medicines in Older Adults. Clin Ther. 2016 Nov;38(11):2340-2372. doi: 10.1016/j.clinthera.2016.09.010. Epub 2016 Oct 15. PMID: 27751669.
* Bouchette D, Akhondi H, Patel P, Quick J. Zolpidem. 2026 Jan. PMID: 28723037.
* Zolpidem. 2006. PMID: 30000324.
* Rosenberg R, Murphy P, Zammit G, Mayleben D, Kumar D, Dhadda S, Filippov G, LoPresti A, Moline M. Comparison of Lemborexant With Placebo and Zolpidem Tartrate Extended Release for the Treatment of Older Adults With Insomnia Disorder: A Phase 3 Randomized Clinical Trial. JAMA Netw Open. 2019 Dec 2;2(12):e1918254. doi: 10.1001/jamanetworkopen.2019.18254. Epub 2019 Dec 2. PMID: 31880796; PMCID: PMC6991236.
* Dauvilliers Y, Zammit G, Fietze I, Mayleben D, Seboek Kinter D, Pain S, Hedner J. Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder. Ann Neurol. 2020 Mar;87(3):347-356. doi: 10.1002/ana.25680. Epub 2020 Feb 5. PMID: 31953863.
* Lou BX, Oks M. Insomnia: Pharmacologic Treatment. Clin Geriatr Med. 2021 Aug;37(3):401-415. doi: 10.1016/j.cger.2021.04.003. Epub 2021 Jun 4. PMID: 34210446.
* Edinoff AN, Wu N, Ghaffar YT, Prejean R, Gremillion R, Cogburn M, Chami AA, Kaye AM, Kaye AD. Zolpidem: Efficacy and Side Effects for Insomnia. Health Psychol Res. 2021;9(1):24927. doi: 10.52965/001c.24927. Epub 2021 Jun 18. PMID: 34746488; PMCID: PMC8567759.
* Saputra BD, Levita J, Mustarichie R. Efficacy, Safety, and Drug-Drug Interactions for Insomnia Therapy in COVID-19 Patients. J Multidiscip Healthc. 2022;15:137-152. doi: 10.2147/JMDH.S337053. Epub 2022 Jan 21. PMID: 35087274; PMCID: PMC8789249.
* De Crescenzo F, D'Alò GL, Ostinelli EG, Ciabattini M, Di Franco V, Watanabe N, Kurtulmus A, Tomlinson A, Mitrova Z, Foti F, Del Giovane C, Quested DJ, Cowen PJ, Barbui C, Amato L, Efthimiou O, Cipriani A. Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis. Lancet. 2022 Jul 16;400(10347):170-184. doi: 10.1016/S0140-6736(22)00878-9. PMID: 35843245.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.